NBY
Novabay Pharmaceuticals Inc
AMEX · Pharmaceuticals
$0.76
+0.01 (+1.10%)
Open$0.79
Previous Close$0.75
Day High$0.94
Day Low$0.76
52W High$27.68
52W Low$20.05
Volume—
Avg Volume127.5K
Market Cap95.90M
P/E Ratio17.60
EPS$1.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+3,658.7% upside
Current
$0.76
$0.76
Target
$28.57
$28.57
$17.04
$28.57 avg
$34.41
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.54M | 19.57M | 22.58M |
| Net Income | 6.11M | 4.44M | 4.92M |
| Profit Margin | 28.4% | 22.7% | 21.8% |
| EBITDA | 8.25M | 7.02M | 9.17M |
| Free Cash Flow | 2.56M | 4.00M | 3.41M |
| Rev Growth | +9.2% | -0.9% | +13.1% |
| Debt/Equity | 0.40 | 0.49 | 0.43 |
Dividend
Dividend Yield2.27%
Annual Dividend$0.55
Payout Ratio39.9%
Frequencyquarterly
Ex-DividendMar 15, 2026
Pay DateApr 4, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |